ARG-1/II inhibitor (AstraZeneca)

N/A

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameARG-1/II inhibitor (AstraZeneca)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionArginase-1 inhibitorsArginase 2 inhibitors
TargetsArginase 2Arginase-1
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Pharmaceuticals Lp
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Pharmaceuticals Lp
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A